These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9253160)
1. Different progress of MDCK cell death after infection by two different influenza virus isolates. Hornícková Z Cell Biochem Funct; 1997 Jun; 15(2):87-93. PubMed ID: 9253160 [TBL] [Abstract][Full Text] [Related]
2. Suitability of MDCK cells grown in a serum-free medium for influenza virus production. Kessler N; Thomas-Roche G; Gérentes L; Aymard M Dev Biol Stand; 1999; 98():13-21; discussion 73-4. PubMed ID: 10494956 [TBL] [Abstract][Full Text] [Related]
3. Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling. Zhirnov OP; Klenk HD Apoptosis; 2007 Aug; 12(8):1419-32. PubMed ID: 17468837 [TBL] [Abstract][Full Text] [Related]
4. Influenza A virus derived from persistently virus-infected cells shows attenuated cytotoxicity in cultured cells but virulent pathogenicity in mice. Jaber Hossain M; Mori I; Liu B; Kimura Y Microb Pathog; 2008 May; 44(5):417-25. PubMed ID: 18162362 [TBL] [Abstract][Full Text] [Related]
5. Influenza circulating strains in Argentina exhibit differential induction of cytotoxicity and caspase-3 in vitro. Mersich SE; Baumeister EG; Riva D; Lewis AP; Cadario ME; Pontoriero AV; Savy VL J Clin Virol; 2004 Oct; 31(2):134-9. PubMed ID: 15364270 [TBL] [Abstract][Full Text] [Related]
6. Streptococcus suis type 2 culture supernatant enhances the infection ability of the Swine influenza virus H3 subtype in MDCK cells. Wang K; Lu C Berl Munch Tierarztl Wochenschr; 2008; 121(5-6):198-202. PubMed ID: 18557523 [TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo influenza virus-inhibitory effects of viramidine. Sidwell RW; Bailey KW; Wong MH; Barnard DL; Smee DF Antiviral Res; 2005 Oct; 68(1):10-7. PubMed ID: 16087250 [TBL] [Abstract][Full Text] [Related]
8. Use of MDCK cells for production of live attenuated influenza vaccine. Liu J; Shi X; Schwartz R; Kemble G Vaccine; 2009 Oct; 27(46):6460-3. PubMed ID: 19559113 [TBL] [Abstract][Full Text] [Related]
9. Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloligosaccharides with a poly(L-glutamic acid) backbone for inhibition of infection by influenza viruses. Totani K; Kubota T; Kuroda T; Murata T; Hidari KI; Suzuki T; Suzuki Y; Kobayashi K; Ashida H; Yamamoto K; Usui T Glycobiology; 2003 May; 13(5):315-26. PubMed ID: 12626382 [TBL] [Abstract][Full Text] [Related]
11. Characterization of various strains of influenza B virus in a neuroblastoma and a glioblastoma cell line. Chan CH; Lee YT; Chang HR; Chan Y; Liu WT J Microbiol Immunol Infect; 2006 Oct; 39(5):380-6. PubMed ID: 17066199 [TBL] [Abstract][Full Text] [Related]
12. Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation. Saito T; Nakaya Y; Suzuki T; Ito R; Saito T; Saito H; Takao S; Sahara K; Odagiri T; Murata T; Usui T; Suzuki Y; Tashiro M J Med Virol; 2004 Oct; 74(2):336-43. PubMed ID: 15332284 [TBL] [Abstract][Full Text] [Related]
13. Infection dynamics and virus-induced apoptosis in cell culture-based influenza vaccine production-Flow cytometry and mathematical modeling. Schulze-Horsel J; Schulze M; Agalaridis G; Genzel Y; Reichl U Vaccine; 2009 May; 27(20):2712-22. PubMed ID: 19428884 [TBL] [Abstract][Full Text] [Related]
14. Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells. Zhirnov OP; Vorobjeva IV; Saphonova OA; Poyarkov SV; Ovcharenko AV; Anhlan D; Malyshev NA J Clin Virol; 2009 Aug; 45(4):322-33. PubMed ID: 19546028 [TBL] [Abstract][Full Text] [Related]
15. Comparative study of influenza virus replication in Vero and MDCK cell lines. Youil R; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Kiseleva I; Shaw AR; DiStefano D J Virol Methods; 2004 Sep; 120(1):23-31. PubMed ID: 15234806 [TBL] [Abstract][Full Text] [Related]
16. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge. Fu TM; Guan L; Friedman A; Schofield TL; Ulmer JB; Liu MA; Donnelly JJ J Immunol; 1999 Apr; 162(7):4163-70. PubMed ID: 10201942 [TBL] [Abstract][Full Text] [Related]
17. Effects of Clinacanthus siamensis leaf extract on influenza virus infection. Wirotesangthong M; Nagai T; Yamada H; Amnuoypol S; Mungmee C Microbiol Immunol; 2009 Feb; 53(2):66-74. PubMed ID: 19291089 [TBL] [Abstract][Full Text] [Related]
18. Production of influenza virus in serum-free mammalian cell cultures. Merten OW; Manuguerra JC; Hannoun C; van der Werf S Dev Biol Stand; 1999; 98():23-37; discussion 73-4. PubMed ID: 10494957 [TBL] [Abstract][Full Text] [Related]
19. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media. Genzel Y; Olmer RM; Schäfer B; Reichl U Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022 [TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of reassortant influenza A viruses propagated in serum-free cultured MDCK-SF1 cells. Voeten JT; Claas EC; Brands R; Palache AM; van Scharrenburg GJ; Rimmelzwaan GF; Osterhaus AD Dev Biol Stand; 1999; 98():77-87; discussion 89-90. PubMed ID: 10494961 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]